Literature DB >> 15695282

Post-marketing surveillance should include effects during pregnancy.

Patricia Yeargin.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 15695282      PMCID： PMC548215          DOI： 10.1136/bmj.330.7486.308-a

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  1 in total

1.  Protecting the embryo from X-rated drugs.

Authors:  J L Mills
Journal:  N Engl J Med       Date:  1995-07-13       Impact factor: 91.245
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.